Study to Evaluate Safety and Activity of Crizotinib With Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma
Clinical trial NCT02270034 · COMPLETED
Trial details
- NCT number
- NCT02270034
- Sponsor
- Grupo Español de Investigación en Neurooncología
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-13
- Primary completion
- 2020-10-26
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.